Las Vegas, NV -- (SBWIRE) -- 12/31/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Vitran Corporation, Inc. (USA) (NASDAQ:VTNC), Organovo Holdings Inc (NYSEMKT:ONVO), Frontline Ltd. (NYSE:FRO), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Vitran Corporation, Inc. (USA) (NASDAQ:VTNC) managed to keep its fall at -3.44% on above-normal volume of 1.91M shares. The stock settled at $6.46 after floating in a range of $6.43 to $6.50. Its latest price has reached market capitalization of $106.15 million. Its 52-week range has been $3.89 to $7.73. Vitran Corporation Inc. (Vitran) is a provider of freight surface transportation and related supply chain services throughout Canada 34 states in the eastern, southeastern, central, southwestern, and western United States.
Has VTNC Found The Bottom and Ready To Move Up? Find Out Here
Organovo Holdings Inc (NYSEMKT:ONVO) traded up on a volume of 3.38 million, lower than its standard daily volume. Shares have gained 5.71% to $9.81. Over the last twelve months, the stock has gained 277.31% and faced a worst price of $2.35. Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., is a development-stage company.
For How Long ONVO’s Gloss will Attract Investors? Find out via this report
Frontline Ltd. (NYSE:FRO) settled -4.40% lower at $3.69 on above-normal volume of 1.72M shares during the last trading day. The stock has its 12-month high at $4.05 and 52-week low price was $1.71. It traded in a range of $3.63 to $3.94 during the last trading day. Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker.
Will FRO Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was down on low volume, trading at a volume of 3.28M shares versus its average daily volume of 4.60 million shares. At $5.88, the stock has attained market capitalization of $1.29 billion. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary,
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)